Inte:Ligand
Vienna, Austria· Est. 1998
Develops computational drug discovery platforms using virtual screening and AI technologies.
Private Company
Total funding raised: $5.8M
About
Develops computational drug discovery platforms using virtual screening and AI technologies.
AI / Machine LearningSmall Molecules
Funding History
2Total raised:$5.8M
Series A$5MJan 15, 2022
Grant$800KMay 15, 2019